Lynne Fahey McGrath, Director at Alzamend Neuro, Inc. (ALZN), sold 25,000 shares at $1.21 ($30K) on 2022-03-28, disclosed to the SEC on 2022-04-08.
Open-market sale of $30k ALZN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |